| Bioactivity | Lerodalcibep (LIB003) is a recombinant fusion protein of a PCSK9-binding domain (adnectin) and human serum albumin. Lerodalcibep is a Lipid-lowering agent. Lerodalcibep can be used for the research of hypercholesterolemia and cardiovascular diseases[1]. |
| Name | Lerodalcibep |
| CAS | 2250073-78-8 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Rossi M, et al. Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice. Am J Cardiovasc Drugs. 2022 Mar;22(2):141-155. |